Genestack

Cambridge, United Kingdom Founded: 2012 • Age: 14 yrs
Bioinformatics platform provided for genomics research and development.

About Genestack

Genestack is a Healthcare company based in Cambridge (United Kingdom) founded in 2012. Bioinformatics platform provided for genomics research and development. The company has 9 employees. Genestack offers products and services including Open Data Manager, Analytical Search, Data Catalog, and Curation Tools. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is GENESTACK LIMITED. Its competitors include Inpharmatica and Genomics; 1 of its 2 listed competitors has raised funding.

Company details

Genestack develops next-generation universal enterprise platform for bioinformatics on and off the cloud for genomics research and development. Its platform is a secure bioinformatics data hosting and computation environment. The platform claims to have advantageous because of its detailed audit, data security, extensive interactive analysis, and data visualization genomics toolbox and bioinformatics tools. It has received a 138.3K grant from Innovate UK to collaborate with Rothamsted Research on the development of agri-genomic technologies for crop improvement. It also collaborated with the Cancer Molecular Diagnostic Laboratory to bring advanced genomic technologies into clinical practice.

  • Headquarters Cambridge, United Kingdom
  • Employees 9
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website genestack.com
  • Social LinkedIn X
  • Legal Name Genestack Limited
  • Date of Incorporation 19 Sep, 2011
  • Jurisdiction CAMBRIDGE, CAMBRIDGESHIRE
Key Metrics
  • Latest Funding Round
    $138.3K (USD), Grant

    Oct 2015

  • Investors
  • Employee Count
    9

Products & Services of Genestack

Genestack offers a comprehensive portfolio of products and services, including Open Data Manager, Analytical Search, Data Catalog, and Curation Tools.

Open Data Manager
Data Management Platform

Harmonizes and integrates life science data for AI workflows.

Analytical Search
Search Tool

Enables queries across studies and omics data via APIs.

Data Catalog
Data Access Tool

Provides access to samples and metadata in life sciences.

Curation Tools
Data Harmonization

Validates metadata to ensure compliance and standardization.

Funding Insights of Genestack

  • Total Rounds 1
  • Last Round Grant β€” $138,300
  • First Round $138,300

    (Oct 2015)

  • Investors Count 1

All 1 funding rounds of Genestack with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2015$138,300Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Genestack

Genestack has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gov.uk.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Online government services and information are provided to users.
1707gov.ukLondon, United Kingdom
Premium access

Investor details for Genestack

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Genestack

13 people are tracked at Genestack (4 in leadership, 9 in team); the tracked headcount is 9.

NameRoleGroup
Dmitriy Pavlov
Head Of EngineeringLeadership
Alexey Dubovenko
Head Of Product And ServicesLeadership
Clare Devlin
Finance DirectorLeadership
Misha Kapushesky
CEOLeadership
Luis Alvarez
Bioinformatic Solution ConsultantTeam
Sharon Ruiz-Lopez
Field Application ScientistTeam
Jelena Pilic
Project Manager | Product & Services TeamTeam
Oleg Kunitsyn
Platform EngineerTeam
Kirill Prusov
Technical Product ManagerTeam
Jonathan Parker
Growth Strategy ConsultantTeam
Boris Megorsky
HRTeam
Daria Matskevich
Senior Information Technology RecruiterTeam
Vladislav T.
Devops Team LeadTeam
Premium access

Complete people profiles for Genestack

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Genestack

2 dated milestones of Genestack across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Genestack is founded.
  2. Funding First funding round of $138K.

Competitors of Genestack

Genestack has 2 listed competitors in our database, 1 of them funded. They include Inpharmatica and Genomics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
inpharmatica.co.uk1998London, United Kingdom62
Developer of predictive informatics based platform for drug discovery
genomics.com2014Oxford, United Kingdom$115.54M
Genomic risk assessment and prevention platform is provided.
Premium access

Detailed competitors of Genestack

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Genestack

The website of Genestack (genestack.com) receives about 1.5K visits a month.

  • Monthly visits
    1.5K

    ▲ 17.2% vs previous month

Similar websites

Websites whose visitors overlap most with Genestack. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
galaxyproject.org
galaxyproject.org
100%
#257,137–
genomicsadventures.wordpress.com
genomicsadventures.wordpress.com
100%
–
biostars.org
89%
#154,376View details
nature.com
72%
33.6M#1,922View details
ccbi.cam.ac.uk
ccbi.cam.ac.uk
63%
–

Top companies in Genomics & Gene Therapy Platforms

2 companies that operate in the same segment as Genestack (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Genestack

Premium access

Complete news archive for Genestack

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Genestack

Genestack was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Genestack is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Genestack has 9 employees.

Genestack develops next-generation universal enterprise platform for bioinformatics on and off the cloud for genomics research and development. Its platform is a secure bioinformatics data hosting and computation environment. The platform claims to have advantageous because of its detailed audit, data security, extensive interactive analysis, and data visualization genomics toolbox and bioinformatics tools. It has received a 138.3K grant from Innovate UK to collaborate with Rothamsted Research on the development of agri-genomic technologies for crop improvement. It also collaborated with the Cancer Molecular Diagnostic Laboratory to bring advanced genomic technologies into clinical practice.

Genestack's top competitors include Inpharmatica and Genomics.

Genestack offers Open Data Manager, Analytical Search, Data Catalog, and Curation Tools.

Genestack has 1 investor. Key investors include Gov.uk.

Genestack operates through Genestack Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available